Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

Healthcare Biotechnology
"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

TELESTA THERAPEUTICS INC > Should be interesting.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Nohandledzepon May 08, 2013 10:06am
219 Views
Post# 21351580

RE: Should be interesting.

RE: Should be interesting.

Tyson, the most interesting things about BNC quarterly releases are the over under on losses, and trying to predict the blame de jour for the delays to the VMC.

 

I am going to take the over on 4.8 mil in losses and I'll go with low water pressure in Belleville for pushing the VMC validation off until Nov/Dec 2013.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities